Disease / condition

Aortic Valve Stenosis,Transcatheter Aortic Valve Replacement clinical trials

Free access to 4 studies·3+ countries·Updated daily3 recruiting
4
Total trials
3+
Countries
3+
Sponsors
3
Recruiting
By phase
N/A4
By status
Recruiting3
Not yet recruit...1
Top countries
Canada2
Belgium,Chile,Czech,Italy,Spain1
Italy1
Top sponsors
Niguarda Hospital2
Hamilton Health Sc...1
Institut universit...1
Recent trials
Latest clinical trials for Aortic Valve Stenosis,Transcatheter Aortic Valve Replacement
NCT06420830Not yet recr...
Valve Performance of the SAPIEN 3 Ultra RESILIA Valve: A Prospective Registry With Central Echocardiography Analysis.
Institut universitaire de card...Canada
NCT06000943Recruiting
Ischemic And Bleeding Risk Assessment After TAVR
Niguarda HospitalBelgium,Chile,Czech,Italy,Spain
NCT06040398Recruiting
The JUMPSTART Program: Encouraging Early Mobilization and Optimizing Recovery of TAVR Patients' Post-hospital Discharge
Hamilton Health Sciences Corpo...Canada
NCT05779787Recruiting
COronary Re-engageMent aFter randOm NavitoR alignmenT (COMFORT STUDY)
Niguarda HospitalItaly
About this record

Access comprehensive clinical trial information for Aortic Valve Stenosis,Transcatheter Aortic Valve Replacement through Pure Global AI's free database. This collection includes 4 clinical trials across multiple phases including N/A. Currently, 3 trials are actively recruiting participants.

Research for Aortic Valve Stenosis,Transcatheter Aortic Valve Replacement is being conducted in Canada, Belgium,Chile,Czech,Italy,Spain, Italy and more. Leading sponsors include Niguarda Hospital and Hamilton Health Sciences Corporation. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 4 clinical trials studying Aortic Valve Stenosis,Transcatheter Aortic Valve Replacement, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 3+ countries.

Top research sponsors include Niguarda Hospital, Hamilton Health Sciences Corporation, Institut universitaire de cardiologie et de pneumologie de Québec, University Laval, among others.